Try our beta test site
6 studies found for:    MitoQ
Show Display Options
Rank Status Study
1 Completed A Trial of MitoQ for the Treatment of People With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: MitoQ
2 Recruiting The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
Condition: Aging
Interventions: Drug: MitoQ;   Drug: Placebo
3 Completed Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Mitoquinone mesylate (MitoQ)
4 Terminated A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Mitoquinone mesylate;   Drug: Placebo
5 Not yet recruiting Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Dietary Supplement: MitoQ;   Dietary Supplement: Placebo
6 Recruiting : Vascular Function in Health and Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Pulmonary Artery Hypertension;   Heart Failure;   Hypertension
Interventions: Other: Maximum Exercise Tests;   Drug: BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate;   Drug: BQ-123;   Drug: Fexofenadine, Ranitidine;   Other: Angiotensin-II, Valsartan;   Drug: Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine;   Drug: BQ-123, MitoQ, BH4

Study has passed its completion date and status has not been verified in more than two years.